Ken Fisher's COGT Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 167,412 shares of Cogent Biosciences, Inc. (COGT) worth $6.44 M, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in COGT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 119,498 shares. Largest reduction occurred in Q4 2025, reducing 55,578 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Cogent Biosciences (COGT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cogent Biosciences (COGT) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +119,498 | Add 249.40% | 167,412 | $38.49 |
| Q4 2025 | -55,578 | Reduce 53.70% | 47,914 | $35.52 |
| Q3 2025 | -7,416 | Reduce 6.69% | 103,492 | $14.36 |
| Q4 2024 | -18,507 | Reduce 14.30% | 110,908 | $7.80 |
| Q3 2024 | -19,630 | Reduce 13.17% | 129,415 | $10.80 |
| Q2 2024 | +47,514 | Add 46.80% | 149,045 | $8.43 |
| Q1 2024 | -260 | Reduce 0.26% | 101,531 | $6.72 |
| Q4 2023 | +33,222 | Add 48.45% | 101,791 | $5.88 |
| Q3 2022 | +68,569 | New Buy | 68,569 | $14.92 |
Ken Fisher's Cogent Biosciences Investment FAQs
Ken Fisher first purchased Cogent Biosciences, Inc. (COGT) in Q3 2022, acquiring 68,569 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Cogent Biosciences, Inc. (COGT) for 15 quarters since Q3 2022.
Ken Fisher's largest addition to Cogent Biosciences, Inc. (COGT) was in Q1 2026, adding 167,412 shares worth $6.44 M.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 167,412 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $6.44 M.
As of the Q1 2026 filing, Cogent Biosciences, Inc. (COGT) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Cogent Biosciences, Inc. (COGT) was 167,412 shares, as reported at the end of Q1 2026.